Demand, Supply and Business Continuity Risks from COVID-19
First written in FY2020. 6 of 11 entries say "Materialised", first in FY2021-Q1. Latest entry: FY2024.
Fuso Chemical moved to the "Worse" side of this theme in 2020, the same year as the typical company in this theme.
The whole theme swung hardest in 2025: 5 of 16 companies on the "Worse" side.
4 other companies' latest entry also says "Softened".
- FY2024SoftenedAnnual report
「In Japan, restrictions on social activity were lifted following the reclassification of COVID-19 as a Class 5 disease, and the economy showed signs of recovery, also supported by stronger inbound demand.」
The filing notes the reclassification of COVID-19 as a Class 5 disease and the lifting of restrictions on social activity, indicating a reduced focus on the previous phase of infection spread and activity restrictions. - FY2023-Q2RestatedAnnual report
「In Japan, the resurgence of COVID-19 had passed its peak and restrictions on socioeconomic activity were being lifted. However, resource and grain prices remained elevated, while the continuing depreciation of the yen drove continued inflation, leaving concerns about the impact on the economy.」
Although the resurgence of infections had passed its peak and restrictions were beginning to be lifted, concerns about the economic impact of inflation and the weaker yen continued. - FY2023-Q1RestatedAnnual report
「In addition, COVID-19 has resurged due to variants, and the outlook remains uncertain.」
The Company identifies the resurgence of infections due to variants and uncertainty over the outlook as continuing business-environment risks. - FY2022RestatedAnnual report
「The future course and prospects for the containment of COVID-19 remain uncertain. However, the Company judged that the impact on the Group's performance was limited and that, based on information available at this time, there was no material impact on accounting estimates. COVID-19 involves many uncertainties, however, and may affect the Group's financial position, operating results and cash flows in the future.」
While describing the impact on performance as limited, the Company continues to disclose the uncertainty surrounding the infection and the possibility of future effects. - FY2022-Q2MaterialisedAnnual report
「Infections are spreading in Southeast Asia and affecting the supply chains of various industries.」
The filing specifically states that the spread of COVID-19 is affecting supply chains in Southeast Asia. - FY2022-Q1MaterialisedAnnual report
「Although positive factors include a recovery in global economic growth and increased IT demand due to advancing digitalization, concerns have emerged, including the spread of variants, intensifying tensions between the United States and China, continuing disruption to ocean shipping, and uncertainty over semiconductor supplies. The outlook therefore remains uncertain.」
The continued spread of variants and restrictions on social activity, along with infection risks including COVID-19, continue to affect actual results and the outlook as sources of uncertainty in the economic environment. - FY2021MaterialisedAnnual report
「Although some markets have been affected by the spread of COVID-19, the overall impact on the Company's performance was limited. However, depending on future developments, the Company may be affected more significantly, so it will communicate with customers as much as possible, work to gather information at an early stage, and respond to risks ahead of time.」
The Company explains that, while some markets were affected by COVID-19, the overall impact on performance was limited. - FY2021-Q3MaterialisedAnnual report
「The impact of the spread of COVID-19 on the performance of the Group during the cumulative third quarter of the current fiscal year was generally limited. However, demand has declined in some industries due to the economic downturn, and the Company will continue to closely monitor developments.」
The Company describes the overall impact of COVID-19 as limited, while explaining that demand has declined in some industries due to the economic downturn. - FY2021-Q2MaterialisedAnnual report
「The impact of the spread of COVID-19 on the performance of the Group during the cumulative second quarter of the current fiscal year was generally limited. However, demand has declined in some industries due to the economic downturn, and the Company will continue to closely monitor developments.」
The Company describes the overall impact of COVID-19 as limited, while explaining that demand has declined in some industries due to the economic downturn. - FY2021-Q1MaterialisedAnnual report
「The impact of the spread of COVID-19 on the performance of the Group during the cumulative first quarter of the current fiscal year was generally limited. However, the impact has begun to emerge in some industries among the Group's business partners, and the Company will continue to closely monitor developments.」
The Company describes the overall impact of COVID-19 as limited, while explaining that its effects have emerged in some industries among business partners. It also reports lower Life Science business sales due to people refraining from going out and downturns in the Chinese and U.S. economies. - FY2020First statedAnnual report
「The global economy in the next period is being significantly affected by the worldwide spread of COVID-19. A prolonged stagnation in economic activity both in Japan and overseas is a concern, and a substantial downturn in the real economy is expected.」
The Company specifically identifies the global spread of COVID-19, economic stagnation, demand fluctuations, site closures and supply chain impacts as new risks. It explains that the impact on performance in the current fiscal year was limited.